O Kamiya
Impact in
-
- Bioactive Compounds and Antitumor Agents
-
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 6
- Cancer Treatment and Pharmacology 4
- Peptidase Inhibition and Analysis 2
-
- Multiple Myeloma Research and Treatments 4
- Acute Myeloid Leukemia Research 2
- Co-authors
- Masahide Kobayashi (5 shared papers)Yoshihisa Kodera (1 shared paper)Masami Hirano (1 shared paper)Hidehiko Saito (4 shared papers)E Nagura (5 shared papers)N Hirabayashi (3 shared papers)Miki Kobayashi (2 shared papers)Masahiro Hirano (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Internal Medicine (1 paper)PubMed (3 papers)Japanese Journal of Cancer Research (2 papers)
- Partner nations
- JapanGreeceSwitzerland
In The Last Decade
O Kamiya
8 papers receiving 30 citations
Peers
Comparison fields: 5 of 20
- Toxicology 3
- Hematology 8
- Oncology 15
- Applied Microbiology and Biotechnology 1
- Molecular Biology 18
Countries citing papers authored by O Kamiya
This map shows the geographic impact of O Kamiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Kamiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Kamiya more than expected).
Fields of papers citing papers by O Kamiya
This network shows the impact of papers produced by O Kamiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Kamiya. The network helps show where O Kamiya may publish in the future.
Co-authors
The 25 scholars most cited alongside O Kamiya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 13 | |
| 2 | [Phase II study of carboplatin in malignant lymphoma]. | 1988 | 6 |
| 3 | 1997 | 3 | |
| 4 | 1999 | 3 | |
| 5 | 1990 | 2 | |
| 6 | [Late phase II study of MST-16 (sobuzoxane) on malignant lymphoma]. | 1991 | 1 |
| 7 | [The continuous-DCMP therapy for acute nonlymphocytic leukemia in elderly patients--comparison with younger patients]. | 1989 | 1 |
| 8 | 2002 | 1 | |
| 9 | 1985 | 0 |
About O Kamiya
O Kamiya is a scholar working on Oncology, Hematology, Molecular Biology, Organic Chemistry and Genetics, having authored 9 papers that have together received 30 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (4 papers), Acute Myeloid Leukemia Research (2 papers), Protein Degradation and Inhibitors (2 papers), Peptidase Inhibition and Analysis (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Breast Cancer Treatment Studies (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Toxicology (3 citations), Hematology (8 citations), Oncology (15 citations), Applied Microbiology and Biotechnology (1 citation) and Molecular Biology (18 citations). O Kamiya has collaborated with scholars based in Japan, Greece and Switzerland. Frequent co-authors include Masahide Kobayashi, Yoshihisa Kodera, Masami Hirano, Hidehiko Saito, E Nagura, N Hirabayashi, Miki Kobayashi, Masahiro Hirano, K Sampi and Ken Naito. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, JNCI Journal of the National Cancer Institute, Internal Medicine, PubMed and Japanese Journal of Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.